Literature DB >> 3985054

Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancy.

O A Kletzky, F Rossman, S I Bertolli, L D Platt, D R Mishell.   

Abstract

This study was performed to establish the dynamics of human chorionic gonadotropin, prolactin, and growth hormone throughout pregnancy in serum and amniotic fluid. Two hundred fifty healthy women at 8 to 42 weeks' gestation were studied. The highest serum human chorionic gonadotropin level was measured between weeks 8 to 12 (53,715 +/- 3574 mIU/ml, mean +/- SEM), with a decline to a mean plateau of 11,806 +/- 1250 mIU/ml from week 18. Amniotic fluid human chorionic gonadotropin had a similar pattern with a mean of 68,100 +/- 8422 mIU/ml at weeks 8 to 10, declining from week 18 to a plateau of 2005 +/- 260 mIU/ml. Human chorionic gonadotropin showed a significant correlation (r = 0.85, p less than 0.001) between levels of both compartments demonstrating an even distribution. Prolactin levels showed a dichotomy of patterns and levels. Serum prolactin showed a continuous rise from 45.3 +/- 14 ng/ml at week 8 to 224 +/- 20 ng/ml at week 36. In contrast, amniotic fluid prolactin remained low until week 14 (33.1 +/- 0.8 ng/ml), followed by a sharp and significant (p less than 0.001) increase to a plateau of 3750 +/- 200 ng/ml between weeks 18 to 26, declining to a second plateau of 500 +/- 50 ng/ml at week 36. Serum growth hormone increased from a mean of 3.5 +/- 1.4 ng/ml seen at weeks 8 to 10 to a mean of 14 +/- 2.0 ng/ml at weeks 28 to 30, followed by a plateau of similar levels. The pattern of growth hormone secretion in amniotic fluid demonstrated a sharp increase during the 14-16 interval with a maximum mean level of 15.5 +/- 1.5 ng/ml and a slow steady decline thereafter. In conclusion, the similar pattern and concentration of human chorionic gonadotropin throughout pregnancy in both maternal and amniotic fluid are probably the result of direct human chorionic gonadotropin diffusion from the placenta. The dissimilar pattern and concentration of prolactin are the result of two different sources of prolactin secretion during pregnancy. Serum prolactin originates from the pituitary and amniotic fluid prolactin from the decidua. Since the pattern of growth hormone secretion resembles that of prolactin, it is possible that growth hormone, like prolactin, is secreted by the same sources.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985054     DOI: 10.1016/0002-9378(85)90665-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Prolactin concentrations in preterm and term pregnancy and labour.

Authors:  M Mazor; R Hershkowitz; F Ghezzi; J Cohen; W Chaim; A Wiznitzer; J Levy; J R Leiberman; M Glezerman
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

3.  The effect of gestational age and labor on placental growth hormone in amniotic fluid.

Authors:  P Mittal; S S Hassan; J Espinoza; J P Kusanovic; S Edwin; F Gotsch; O Erez; N G Than; S Mazaki-Tovi; R Romero
Journal:  Growth Horm IGF Res       Date:  2007-10-01       Impact factor: 2.372

4.  Influence of norepinephrine administration upon pituitary hormone secretion in normal men.

Authors:  G N Mileikowsky; R M Farmer; V De Quattro; O A Kletzky
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

5.  β-human chorionic gonadotropin assay in vaginal washing fluid for the accurate diagnosis of premature rupture of membranes during late pregnancy.

Authors:  Orhan Temel; Ebru Cöğendez; Selçuk Selçuk; Mehmet Reşit Asoğlu; Erdal Kaya
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

6.  Urinary hCG patterns during the week following implantation.

Authors:  P A Nepomnaschy; C R Weinberg; A J Wilcox; D D Baird
Journal:  Hum Reprod       Date:  2007-12-14       Impact factor: 6.918

7.  Human placental lactogen induces CYP2E1 expression via PI 3-kinase pathway in female human hepatocytes.

Authors:  Jin Kyung Lee; Hye Jin Chung; Liam Fischer; James Fischer; Frank J Gonzalez; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2014-01-09       Impact factor: 3.922

8.  Hormonal regulation of BCRP expression in human placental BeWo cells.

Authors:  Honggang Wang; Jashvant D Unadkat; Qingcheng Mao
Journal:  Pharm Res       Date:  2007-09-06       Impact factor: 4.580

9.  Prolactin modifies the in vitro LPS-induced chemotactic capabilities in human fetal membranes at the term of gestation.

Authors:  Estefanía Núñez-Sánchez; María Del Pilar Flores-Espinosa; Ismael Mancilla-Herrera; Leticia González; José Cisneros; Andrea Olmos-Ortiz; Braulio Quesada-Reyna; Martha Granados-Cepeda; Veronica Zaga-Clavellina
Journal:  Am J Reprod Immunol       Date:  2021-03-16       Impact factor: 3.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.